HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$1.78
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$1.78
Sarado: Nob 28, 1:01:55 PM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.83
Sakop ng araw
$1.78 - $1.85
Sakop ng taon
$1.32 - $3.10
Market cap
143.15M USD
Average na Volume
810.16K
P/E ratio
104.52
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 17.85M | -0.60% |
Gastos sa pagpapatakbo | 7.40M | 32.24% |
Net na kita | 2.36M | -27.22% |
Net profit margin | 13.19 | -26.80% |
Kita sa bawat share | — | — |
EBITDA | 2.50M | -42.06% |
Aktuwal na % ng binabayarang buwis | -5.18% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 29.37M | 7.15% |
Kabuuang asset | 82.26M | 33.63% |
Kabuuang sagutin | 29.36M | 0.79% |
Kabuuang equity | 52.91M | — |
Natitirang share | 80.42M | — |
Presyo para makapag-book | 2.77 | — |
Return on assets | 6.63% | — |
Return on capital | 9.16% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 2.36M | -27.22% |
Cash mula sa mga operasyon | -3.73M | -190.91% |
Cash mula sa pag-invest | -504.00K | -102.48% |
Cash mula sa financing | 0.00 | 100.00% |
Net change in cash | -4.25M | -205.94% |
Malayang cash flow | -6.02M | -671.68% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
213
